Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 455.00 | |
5 mg | In stock | $ 956.00 | |
10 mg | In stock | $ 1,290.00 | |
25 mg | In stock | $ 1,920.00 | |
50 mg | In stock | $ 2,590.00 | |
100 mg | In stock | $ 3,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 928.00 |
Description | Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others. |
Molecular Weight | 299.35 |
Formula | C15H13N3O2S |
CAS No. | 1007581-62-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11 mg/mL (36.75 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cancer-Targeting Compound 1 1007581-62-5 Others Cancer Targeting Compound 1 CancerTargeting Compound 1 inhibitor inhibit